GLENMARK LIFE SCIENCES LIMITED |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 847.2 INR | -0.80% |
|
+0.52% | +28.94% |
| 07-11 | Glenmark Pharmaceuticals to Sell 7.84% Stake in Glenmark Life Sciences | MT |
| 07-10 | Glenmark Pharma to Sell 7.84% Stake in Glenmark Life via Offer for Sale | CI |
Evolution of the average Target Price on Glenmark Life Sciences Limited
Price target over the last 5 years
History of analyst recommendation changes
a37c6c44a765.a0CfLKAdWH5OA-AjHY67JtaGFcXOsR7fBpIh4ma5NQQ.Dh_XGsltAi8PZaNZb7zPE5K-Uqu5_nuzVaVohSWIfHQacuVF2ntuDh17jw~edc98d35f70a95ccf707ca547e154cac
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
855.1
INR
Average target price
932.6
INR
Spread / Average Target
+9.06%
High Price Target
1,040
INR
Spread / Highest target
+21.62%
Low Price Target
790
INR
Spread / Lowest Target
-7.61%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D
EPS Revisions
- Stock Market
- Equities
- GLS Stock
- GLS Stock
- Consensus Glenmark Life Sciences Limited
